Top Markets
Coin of the day
Chordia Therapeutics Inc. Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

190A
Rank in Stocks #26480
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
Share Price
$0.53499835
Market Cap
$40.24M
Change (1 day)
2.50%
Change (1 year)
-58.07%
Country
JP
Trade Chordia Therapeutics Inc. (190A)

Category

Stock split history for Chordia Therapeutics Inc. (190A)
Chordia Therapeutics Inc. stock (symbol: 190A) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 20, 2026.
One 190A share bought prior to Aug 20, 2026 would equal to 0 190A shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US